Skip to main navigation Skip to search Skip to main content

Cardiovascular risk in prostate cancer working group

Activity: Consultancy types › Contribution to the work of national or international committees and working groups

Period30 Apr 2015
Work forFerring Pharmaceutical Company, United Kingdom